Where the Money Goes

You are here

Home » Where the Money Goes » ALSF Childhood Cancer Research Grants

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Jump to search filters

ALSF Funded Research Projects

Project Title Institution / Principal Investigator(s) Grant Type Year Statesort descending
Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database Huntsman Cancer Institute / Joshua Schiffman, MD Epidemiology Grants 2012 Utah
GSTM4, a novel target for treating Ewing sarcoma. Huntsman Cancer Institute / Wen Luo Young Investigator Grants 2009 Utah
Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database Huntsman Cancer Institute / Joshua Schiffman, MD Epidemiology Grants 2010 Utah
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma. Huntsman Cancer Institute / Stephen Lessnick Innovation Grants 2009 Utah
The TC3 Line, a Zebrafish Model of T-Cell Malignancy Huntsman Cancer Institute / Nathan Meeker, MD Young Investigator Grants 2008 Utah
Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries University of Utah / Anne Kirchhoff, PhD/MPH Epidemiology Grants 2019 Utah
Identification of predisposition genes for Ewing sarcoma segregating in high-risk pedigrees Huntsman Cancer Institute / Lisa Cannon-Albright, PhD Innovation Grants 2012 Utah
Relationships Between Symptoms and the Hospital Care Environment in Children and Adolescents with Cancer Huntsman Cancer Institute / Lauri Linder Nurse Researcher Grants 2010 Utah
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP) Innovation Grants 2015 Virginia
LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma University of Virginia, School of Medicine / Michael Engel, MD/PhD Reach Grants 2016 Virginia

Pages